 | Up a level |
Gantenbein, Andreas R; Bonvin, Christophe; Kamm, Christian P; Schankin, Christoph J; Zecca, Chiara; Zieglgänsberger, Dominik; Merki-Feld, Gabriele Susanne; Pohl, Heiko; Rudolph, Nicole; Ryvlin, Philippe; Agosti, Reto; Schäfer, Elisabeth; Meyer, Ina; Kulartz-Schank, Monika; Arzt, Michael E (2024). Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results. Journal of neurology, 271(8), pp. 5402-5410. Springer 10.1007/s00415-024-12470-6
Merki-Feld, Gabriele; Dietrich, Hanna; Imesch, Patrick; Gantenbein, Andreas R; Sandor, Peter; Schankin, Christoph J (2024). Investigating migraine phenotype and dynamics in women with endometriosis: an observational pilot study. Acta neurologica Belgica, 124(4), pp. 1263-1271. Springer 10.1007/s13760-024-02484-2
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Nervenarzt, 94(4), pp. 306-317. Springer 10.1007/s00115-022-01403-1
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Nervenarzt, 94(4), pp. 318-319. Springer 10.1007/s00115-022-01435-7
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Der Schmerz, 37(1), pp. 5-16. Springer 10.1007/s00482-022-00671-9
Goßrau, Gudrun; Förderreuther, Stefanie; Ruscheweyh, Ruth; Ruschil, Victoria; Sprenger, Till; Lewis, David; Kamm, Katharina; Freilinger, Tobias; Neeb, Lars; Malzacher, Volker; Meier, Uwe; Gehring, Klaus; Kraya, Torsten; Dresler, Thomas; Schankin, Christoph J; Gantenbein, Andreas R; Brössner, Gregor; Zebenholzer, Karin; Diener, Hans-Christoph; Gaul, Charly; ... (2023). [Erratum to: Consensus statement of the migraine and headache societies (DMKG, ÖKSG, and SKG) on the duration of pharmacological migraine prophylaxis]. Schmerz, 37(1), pp. 17-18. Springer 10.1007/s00482-022-00691-5
Gantenbein, Andreas R; Agosti, Reto; Kamm, Christian P; Landmann, Gunther; Meier, Niklaus; Merki-Feld, Gabriele Susanne; Petersen, Jens A; Pohl, Heiko; Ryvlin, Philippe; Schankin, Christoph J; Viceic, Dragana; Zecca, Chiara; Schäfer, Elisabeth; Meyer, Ina; Arzt, Michael E (2022). Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. The journal of headache and pain, 23(1), p. 161. BioMed Central 10.1186/s10194-022-01530-9
Gantenbein, Andreas R; Agosti, Reto; Kamm, Christian P; Landmann, Gunther; Meier, Niklaus; Merki-Feld, Gabriele Susanne; Petersen, Jens A; Pohl, Heiko; Ryvlin, Philippe; Schankin, Christoph J; Viceic, Dragana; Zecca, Chiara; Schäfer, Elisabeth; Meyer, Ina; Arzt, Michael E (2022). Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results. The journal of headache and pain, 23(1), p. 142. 10.1186/s10194-022-01515-8
Gantenbein, Andreas R; Agosti, Reto; Gobbi, Claudio; Flügel, Dominique; Schankin, Christoph J.; Viceic, Dragana; Zecca, Chiara; Pohl, Heiko (2021). Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study. Cephalalgia, 41(11-12), pp. 1181-1186. Sage Publications 10.1177/03331024211014616
García-Azorín, David; Do, Thien Phu; Gantenbein, Andreas R; Hansen, Jakob Møller; Souza, Marcio Nattan P; Obermann, Mark; Pohl, Heiko; Schankin, Christoph J.; Schytz, Henrik Winther; Sinclair, Alexandra; Schoonman, Guus G; Kristoffersen, Espen Saxhaug (2021). Delayed headache after COVID-19 vaccination: a red flag for vaccine induced cerebral venous thrombosis. The journal of headache and pain, 22(1), p. 108. BioMed Central 10.1186/s10194-021-01324-5
Pohl, Heiko; Andrée, Colette; Biethahn, Silke; Emmenegger, Mark; Flügel, Dominique; Jung, Hans H; Kleinschmidt, Andreas; Palla, Antonella; Sandor, Peter; Schankin, Christoph; Schmidt, Holger; Sturzenegger, Mathias; Gantenbein, Andreas R (2021). [Smarter Medicine in Headache Care - presentation and discussion of 5 recommendations]. Therapeutische Umschau, 78(7), pp. 341-348. Huber 10.1024/0040-5930/a001282
Pohl, Heiko; Do, Thien Phu; García-Azorín, David; Hansen, Jakob Møller; Kristoffersen, Espen Saxhaug; Nelson, Sarah E; Obermann, Mark; Sandor, Peter S; Schankin, Christoph J.; Schytz, Henrik Winther; Sinclair, Alexandra; Schoonman, Guus G; Gantenbein, Andreas R (2021). Green Flags and headache: A concept study using the Delphi method. Headache, 61(2), pp. 300-309. Wiley-Blackwell 10.1111/head.14054
Landmann, Gunther; Dumat, Wolfgang; Egloff, Niklaus; Gantenbein, Andreas R; Matter, Sibylle; Pirotta, Roberto; Sándor, Peter S; Schleinzer, Wolfgang; Seifert, Burkhardt; Sprott, Heiko; Stockinger, Lenka; Riederer, Franz (2017). Bilateral Sensory Changes and High Burden of Disease in Patients with Chronic Pain and Unilateral Nondermatomal Somatosensory Deficits: A Quantitative Sensory Testing and Clinical Study. The clinical journal of pain, 33(8), pp. 746-755. Lippincott Williams & Wilkins 10.1097/AJP.0000000000000456
Landmann, Gunther; Egloff, Niklaus; Gantenbein, Andreas R; Sandor, Peter S; Riederer, Franz (2016). Störungen der Schmerzverarbeitung: Nichtdermatomales sensorisches Defizit – ein Marker der Schmerzchronifizierung. Der informierte Arzt(7), pp. 32-35. Aerzteverlag medinfo AG
Riederer, Franz; Landmann, Gunther; Gantenbein, Andreas R; Stockinger, Lenka; Egloff, Niklaus; Sprott, Haiko; Schleinzer, Wolfgang; Pirrotta, Roberto; Dumat, Wolfgang; Luechinger, Roger; Baumgartner, Christoph; Kollias, Spyridon; Sándor, Peter S (2015). Nondermatomal somatosensory deficits in chronic pain are associated with cerebral grey matter changes. World journal of biological psychiatry, 18(3), pp. 227-238. Informa Healthcare 10.3109/15622975.2015.1073356
Gantenbein, Andreas R; Sarikaya, Hakan; Riederer, Franz; Goadsby, Peter J (2015). Postoperative hemicrania continua-like headache - a case series. The Journal of Headache and Pain, 16(41), p. 526. Springer 10.1186/s10194-015-0526-4
Sarikaya, Hakan; Yilmaz, Murat; Luft, Andreas R; Gantenbein, Andreas R (2012). Different pattern of clinical deficits in stroke mimics treated with intravenous thrombolysis. European neurology, 68(6), pp. 344-9. Basel: Karger 10.1159/000337677
